Preterm patent ductus arteriosus: A continuing conundrum for the neonatologist?
Author:
- 1 August 2015
- journal article
- review article
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 20 (4) , 272-277
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled TrialPLOS ONE, 2013
- Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus TreatmentPediatrics, 2011
- Efficacy and Safety of Oral Versus Intravenous Ibuprofen in Very Low Birth Weight Preterm Infants with Patent Ductus ArteriosusThe Journal of Pediatrics, 2011
- Early Surgical Ligation Versus a Conservative Approach for Management of Patent Ductus Arteriosus That Fails to Close after Indomethacin TreatmentThe Journal of Pediatrics, 2010
- An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic studyBritish Journal of Clinical Pharmacology, 2008
- Patent ductus arteriosus: lack of evidence for common treatmentsArchives of Disease in Childhood - Fetal and Neonatal Edition, 2007
- Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative studyThe Journal of Pediatrics, 1983
- Prophylactic Indomethacin Therapy for Patent Ductus Arteriosus in Very-Low-Birth-Weight InfantsNew England Journal of Medicine, 1982
- Early closure of the patent ductus arteriosus in very low-birth-weight infants: A controlled trialThe Journal of Pediatrics, 1981
- Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus—a double-blind controlled studyThe Journal of Pediatrics, 1981